当前位置：首页 SCI期刊 SCIE期刊医学中科院4区 JCRQ2 期刊介绍(非官网)

Clinics And Research In Hepatology And GastroenterologySCIE

国际简称：CLIN RES HEPATOL GAS 参考译名：肝病学和胃肠病学的诊所和研究

中科院分区
4区
CiteScore分区
Q2
JCR分区
Q2

基本信息：: ISSN：2210-7401; E-ISSN：2210-741X; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：FRANCE; 出版商：Elsevier Masson; 出版语言：English; 出版周期：6 issues/year; 出版年份：2011; 研究方向：GASTROENTEROLOGY & HEPATOLOGY

评价信息：: 影响因子：2.6; H-index：51; CiteScore指数：4.3; SJR指数：0.676; SNIP指数：0.616

发文数据：: Gold OA文章占比：27.16%; 研究类文章占比：73.87%; 年发文量：111; 自引率：0.0370...; 开源占比：0.105; 出版撤稿占比：0; 出版国人文章占比：0.23; OA被引用占比：0.0018...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Clinics And Research In Hepatology And Gastroenterology期刊介绍

Clinics and Research in Hepatology and Gastroenterology publishes high-quality original research papers in the field of hepatology and gastroenterology. The editors put the accent on rapid communication of new research and clinical developments and so called "hot topic" issues. Following a clear Editorial line, besides original articles and case reports, each issue features editorials, commentaries and reviews. The journal encourages research and discussion between all those involved in the specialty on an international level. All articles are peer reviewed by international experts, the articles in press are online and indexed in the international databases (Current Contents, Pubmed, Scopus, Science Direct).

Clinics and Research in Hepatology and Gastroenterology is a subscription journal (with optional open access), which allows you to publish your research without any cost to you (unless you proactively chose the open access option). Your article will be available to all researchers around the globe whose institution has a subscription to the journal.

期刊简介Clinics And Research In Hepatology And Gastroenterology期刊介绍

《Clinics And Research In Hepatology And Gastroenterology》自2011出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：偏慢,4-8周
医学
GASTROENTEROLOGY & HEPATOLOGY
SCIE
中科院4区
非预警

Cite Score数据（2024年最新版）Clinics And Research In Hepatology And Gastroenterology Cite Score数据

CiteScore：4.3
SJR：0.676
SNIP：0.616

学科类别	分区	排名	百分位
大类：Medicine 小类：Gastroenterology	Q2	77 / 167	54%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Clinics And Research In Hepatology And Gastroenterology 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	4区	GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学	4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Clinics And Research In Hepatology And Gastroenterology JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	67 / 143	53.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：GASTROENTEROLOGY & HEPATOLOGY	SCIE	Q2	70 / 143	51.4%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
France134
CHINA MAINLAND124
Italy36
GERMANY (FED REP GER)35
USA32
Spain22
Portugal11
Belgium10
Brazil9
Switzerland9

本刊中国学者近年发表论文

1、Comparing high-dose dual therapy with bismuth-containing quadruple therapy for the initial eradication of Helicobacter pylori infection on Hainan Island: A randomized, multicenter clinical trial
Author: Liu, Dan-Ni; Wang, Qiu-Yan; Li, Pei -Yuan; Wu, Dong-Han; Pan, Jing; Chen, Zheng-Yi; Li, Yan-Qiang; Han, Xiang-Yang; Lan, Cheng; Tang, Jing; Tan, Yan; Mo, Cui-Yi; Yang, Wei-Zhong; Han, Jun-Ling; Huang, Xiao-Xi

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 5, pp. -. DOI: 10.1016/j.clinre.2023.102125
2、Efficacy and safety of no-touch radiofrequency ablation for small hepatocellular carcinoma-a systematic review and single-arm meta-analysis
Author: Du, Fei; Zhang, Lingkai; Zhang, Yongxuan; Fan, Haining; Ren, Li

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102069
3、Metabolic-associated fatty liver disease and the risk of cardiovascular disease
Author: Zhang, Pengwei; Dong, Xianhui; Zhang, Wei; Wang, Shiyin; Chen, Chen; Tang, Jiake; You, Yao; Hu, Siqi; Zhang, Shenghui; Wang, Chunyi; Wen, Wen; Zhou, Mengyun; Tan, Tao; Qi, Guanming; Li, Li; Wang, Mingwei

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102063
4、The addition of camrelizumab is effective and safe among unresectable hepatocellular carcinoma patients who progress after drug-eluting bead transarterial chemoembolization plus apatinib therapy
Author: Wang, Manzhou; Sun, Limin; Han, Xinwei; Ren, Jianzhuang; Li, Hao; Wang, Wenhui; Xu, Wenze; Liang, Chao; Duan, Xuhua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102060
5、Global burden of non-alcoholic fatty liver disease in 204 countries and territories from 1990 to 2019
Author: Tian, Hongzhan; Zhang, Kexin; Hui, Zongguang; Ren, Fangbing; Ma, Yanhui; Han, Fang; Sun, Xiaodong; Kan, Chengxia; Hou, Ningning

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102068
6、LncRNA ZFAS1 ameliorates injury led by non- alcoholic fatty liver disease via suppressing lipid peroxidation and inflammation
Author: Liu, Lu; Sun, Sen; Li, Xiaohua

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 1, pp. -. DOI: 10.1016/j.clinre.2022.102067
7、Transarterial chemoembolization failure in patients with hepatocellular carcinoma: Incidence, manifestation and risk factors
Author: Zhang, Lijie; Zhang, Xin; Li, Qing; Makamure, Joyman; Liu, Ziyi; Zhao, Dan; Li, Xin; Shi, Heshui; Zheng, Chuansheng; Liu, Fengyong; Liang, Bin

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102071
8、T lymphocyte-mediated pyroptosis: A new regulatory mechanism in non-viral liver disease
Author: Xiong, Wanyuan; Qian, Zibing; Mao, Xiaorong; Li, Junfeng

Journal: CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY. 2023; Vol. 47, Issue 2, pp. -. DOI: 10.1016/j.clinre.2022.102070